We have profiled the sensitivity of numerous cell surface markers to the enzymatic cocktail used to dissociate tumors. For inquiries on specific markers, please contact info@dls.com.
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter
Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions
NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter
Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions
NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con